Caribou Biosciences

Allogene Therapeutics

The company develops off-the-shelf allogeneic CAR T-cell therapies for patients with blood cancers, solid tumours and autoimmune diseases.

Orca Bio

This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.

Appia Bio

This company develops engineered allogeneic cell therapies from hematopoietic stem cells for cancer patients.

Lyell Immunopharma

This biopharmaceutical company develops chimeric antigen receptor T-cell therapies to treat patients with hematologic malignancies and solid tumours.

CARGO Therapeutics

This biotechnology company develops engineered cell therapies to treat cancer patients with relapsed or resistant lymphoma.

Arcellx

This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.

Autolus Therapeutics

This company develops programmed T-cell therapies for patients with cancer and autoimmune diseases.

Artiva Biotherapeutics

The company develops allogeneic natural killer cell therapies for patients with autoimmune diseases and cancer.